Esperion Therapeutics (ESPR) 'Significantly Undervalued' Despite Move - Needham & Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to Esperion Therapeutics (ESPR) 'Significantly Undervalued' Despite Move - Needham & Company
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.18 --0 (-0%)
Previous Close $3.18    52 Week High $30.41 
Open $3.18    52 Week Low $9.40 
Day High $3.18    P/E N/A 
Day Low $3.18    EPS $-21.87 
Volume 22